Nubeqa

Active Ingredient(s): Darolutamide
FDA Approved: * July 30, 2019
Pharm Company: * BAYER HEALTHCARE
Category: Cancer

Darolutamide, sold under the brand name Nubeqa, is an antiandrogen medication which is used in the treatment of non-metastatic castration-resistant prostate cancer in men.[6][2][3][7][8] It is specifically approved to treat non-metastatic castration-resistant prostate cancer (nmCRPC) in conjunction with surgical or medical castration.[2] The medication is taken by mouth twice per day with food.&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Nubeqa 300 mg Oral Tablet, Film Coated

NDC: 50419-395

Labeler:

Bayer Healthcare Pharmaceuticals Inc.